During COVID-19 and its aftermath it is important to consider the impacts of the pandemic and social and physical isolation on women’s health. This sheet explores adaptations to practice for service organizations and frontline workers, to respond to concerning trends in intimate partner violence (IPV) and substance use in the COVID-19 context.
Respiratory illnesses like COVID-19 are spread in a few ways, including through the air. When people are together indoors, infections can spread more easily.
Understanding the circumstances that contribute to these deaths is urgently needed to inform interventions and policies to prevent opioid-related mortality in the midst of the COVID-19 pandemic.
Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses
Pandemic response measures such as physical distancing and social isolation have disrupted the healthcare and support services that people who use or have used substances and their communities typically rely on.
This is 1 of 6 guidance documents, developed by CRISM at the request of federal governemnt. Collectively, the 6 documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic
This document is 1 of 6 guidance documents developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic.
COVID-19 pandemic compounds an ongoing public health crisis. There is a heightened need to reduce avoidable pressures on healthcare systems and support people who use opioids.
Guidance for service providers on how to alter harm reduction practices during pandemic to reduce spread of COVID-19 | Alberta Health Service COVID guidance
The Canadian Drug Policy Coalition is based out of Simon Fraser University’s Faculty of Health Sciences.